EN
HI
Summary
As of 25 Sep, 2026, Concord Biotech stock price is ₹1454.8. During the trading session, the stock has moved between an intraday low of ₹1439.20 and an intraday high of ₹1479.00. Over the last 52 weeks, Concord Biotech has traded between ₹987.00 and ₹1667.60.
The stock has recorded a trading volume of 1,03,798 shares,. Its Average Traded Price (ATP) is ₹1458.33, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 2 @ ₹1454.80.
Concord Biotech has an upper circuit limit of ₹1774.50 and a lower circuit limit of ₹1183.10. The total value traded stands at ₹15.14 CR, and the delivery percentage for the day is 43.91%.
The stock is currently traded with a market lot size of 1. Concord Biotech also offers a dividend yield of 0.48%.
Concord Biotech Share Price Chart
Concord Biotech Share Key Metrics
Volume
1.04 L
Market Cap
15470.64 CR
LTQ@LTP
2@1454.80
ATP
1458.33
Var Margin
20.39 %
Circuit Range
1183.1-1774.5
Delivery %
43.91 %
Value
15.14 CR
ASM/GSM
No
Market Lot
1
Concord Biotech Fundamentals
P/E Ratio
59.23
P/B Ratio
7.87
Div. Yield
0.48
Sector P/E
38.55
Sector P/B
3.7
Sec. Div. Yield
0.51
Concord Biotech Resistance and Support
Pivot 1500
Resistance
First Resistance
1527.3
Second Resistance
1575.8
Third Resistance
1603.1
Support
First Support
1451.5
Second Support
1424.2
Third Support
1375.7
Concord Biotech Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 25 2026 | 1464.8 | 1454.8 | -1.62% | 1479 | 1439.2 |
| Thu Sep 24 2026 | 1548.5 | 1478.8 | -5.22% | 1548.5 | 1472.69 |
| Wed Sep 23 2026 | 1540.19 | 1560.3 | 1.82% | 1568 | 1518.9 |
Concord Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-31 | Quarterly Results |
| 2026-05-29 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-05-29 | Audited Results & Final Dividend |
| 2025-02-13 | Quarterly Results |
| 2024-11-11 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Concord Biotech News
Concord Biotech Ltd - 543960 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Concord Biotech proposes a 1:1 bonus equity share issue and an increase in authorized share capital to ₹22 crores through a postal ballot. The e-voting period for these resolutions is from September 25 to October 24, 2026.
Sep 24 2026 17:36:25
Concord Biotech Ltd - 543960 - Board Meeting Outcome for The Board Of Director At Its Meeting Held Today I.E. Wednesday, September 23, 2026, Has Inter-Alia Considered And Approved Issuance Of Bonus Shares & Increase In The Authorised Share Capital Of The Company.
Concord Biotech board approved a 1:1 bonus share issue, effectively doubling the number of equity shares. Additionally, the authorized share capital was increased from ₹11 crore to ₹22 crore. Bonus shares are expected to be credited by November 22, 2026.
Sep 23 2026 17:07:00
Read More
Concord Biotech Management
| Name | Position |
|---|---|
| Sudhir Vaid | Chairman & Managing Director |
| Ankur Vaid | Joint Managing Director & CEO |
Concord Biotech Similar Stocks
Cohance Lifesciences Ltd.
458.40
4.25 (0.94%)
Eris Lifesciences Ltd.
1258.50
-16.10 (1.26%)
Poly Medicure Ltd.
1730.70
14.70 (0.86%)
Jubilant Pharmova Ltd.
1072.90
9.05 (0.85%)
Alembic Pharmaceuticals Ltd.
855.00
5.00 (0.59%)
Vijaya Diagnostic Centre Ltd.
1520.00
-6.50 (0.43%)
Marksans Pharma Ltd.
335.80
-1.60 (0.47%)
Dr. Agarwal's Health Care Ltd.
502.40
0.30 (0.06%)
Molbio Diagnostics Ltd.
1253.70
7.50 (0.60%)
Concord Biotech FAQs
The Buying Price of Concord Biotech share is 1454.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Concord Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Concord Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Concord Biotech shares is 59.23. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Concord Biotech shares is 7.87. Useful to assess the stock's value relative to its book value.
To assess Concord Biotech’s valuation compare Sector P/E, P/B which are 38.55 & 3.7 with sector averages, along with growth rates and financial metrics.
The Market Cap of Concord Biotech is 15470.64 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Concord Biotech share price is 1667.60 & 987.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Concord Biotech belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in CONCORDBIO
Or Download Choice FinX App
Invest in CONCORDBIO
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade